Literature DB >> 22841814

Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome.

Grethe S Birketvedt1, Allan Geliebter, Ingrid Kristiansen, Yngve Firgenschau, Rasmus Goll, Jon R Florholmen.   

Abstract

The regulatory peptide ghrelin has been proposed to help mediate both hunger and sleep. The neuroendocrine circadian patterns in the night eating syndrome (NES) have been distinguished by an attenuated nocturnal rise in the plasma concentrations of melatonin and leptin and a greater increase in the concentrations of cortisol. In this study we wanted to test the hypothesis that night eaters have disturbances in the circadian levels of ghrelin, growth hormone (GH) and associated regulatory peptides. In 12 female night eaters (6 normal weight and 6 overweight), and 25 healthy controls (12 normal weight and 13 overweight), blood was sampled over a 24-hour period. Four meals were served from 8 AM to 8 PM, and blood samples were drawn every second hour for determination of plasma ghrelin concentrations and GH by radioimmunoassay (RIA). Analysis of serum GH, IGF-1, IGFBP-3 and prolactin were performed by ELISA. In healthy normal weight subjects there was a slight but non significant nocturnal increase of ghrelin, whereas a more or less flat curve was observed for healthy overweight, NES normal weight and NES overweight patients. The RMANOVA analysis showed a significant independent lowering effect of overweight on the grand mean of ghrelin. No direct effects on NES normal weight and overweight subjects were found, but a near-significant interaction was found between healthy overweight and overweight NES subjects. There were independent significant lowering effects of overweight and NES on the serum GH levels. During the time course no changes in the serum levels of IGF-1 or IGFB-3 were observed. Independent significant lowering effects of overweight and NES on the levels of IGF-1 were detected, whereas a near significant reduction in the global levels of IGFBP-3 was observed in both NES groups. Finally, significant nocturnal changes were observed for serum levels of prolactin in all four subgroups. Grand mean levels tended to be higher in NES subjects whereas the opposite was observed in healthy overweight (ns). We conclude that in both NES groups and in healthy overweight subjects more or less attenuated ghrelin and GH secretions were observed, whereas divergent secretions were observed for prolactin.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841814     DOI: 10.1016/j.appet.2012.07.015

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  11 in total

1.  The relationship between serum levels of prolactin and growth hormone in the early postnatal period.

Authors:  Jonathan Daliot; Tami Laron-Kenet; Mohammad Wattad; Anat Ben-Dor; Pearl Lilos; Zvi Laron
Journal:  Pediatr Res       Date:  2017-08-02       Impact factor: 3.756

Review 2.  Sleep, sleep disturbance, and fertility in women.

Authors:  Jacqueline D Kloss; Michael L Perlis; Jessica A Zamzow; Elizabeth J Culnan; Clarisa R Gracia
Journal:  Sleep Med Rev       Date:  2014-10-18       Impact factor: 11.609

3.  Prospective association between late evening food consumption and risk of prediabetes and diabetes: the Whitehall II cohort study.

Authors:  K Faerch; J S Quist; A Hulman; D R Witte; A G Tabak; E J Brunner; M Kivimäki; M E Jørgensen; S Panda; D Vistisen
Journal:  Diabet Med       Date:  2019-04-11       Impact factor: 4.359

4.  Morning and afternoon appetite and gut hormone responses to meal and stress challenges in obese individuals with and without binge eating disorder.

Authors:  S Carnell; C Grillot; T Ungredda; S Ellis; N Mehta; J Holst; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2017-12-12       Impact factor: 5.095

5.  Neuroendocrine Profile in the Night Eating Syndrome.

Authors:  Grethe Støa Birketvedt; Allan Geliebter; Jon Florholmen; Marci E Gluck
Journal:  Curr Obes Rep       Date:  2014-03

Review 6.  Sleep and Eating Disorders.

Authors:  Kelly C Allison; Andrea Spaeth; Christina M Hopkins
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

Review 7.  Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.

Authors:  Laura E Dichtel; Jose Cordoba-Chacon; Rhonda D Kineman
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

8.  Interpersonal stressors predict ghrelin and leptin levels in women.

Authors:  Lisa M Jaremka; Martha A Belury; Rebecca R Andridge; William B Malarkey; Ronald Glaser; Lisa Christian; Charles F Emery; Janice K Kiecolt-Glaser
Journal:  Psychoneuroendocrinology       Date:  2014-06-30       Impact factor: 4.905

9.  Diurnal Variation of Hormonal and Lipid Biomarkers in a Molecular Epidemiology-Like Setting.

Authors:  Linda W M van Kerkhof; Kirsten C G Van Dycke; Eugene H J M Jansen; Piet K Beekhof; Conny T M van Oostrom; Tatjana Ruskovska; Nevenka Velickova; Nikola Kamcev; Jeroen L A Pennings; Harry van Steeg; Wendy Rodenburg
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

Review 10.  Intermittent feeding schedules--behavioural consequences and potential clinical significance.

Authors:  Michelle Murphy; Julian G Mercer
Journal:  Nutrients       Date:  2014-03-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.